Long-term outcomes of generalized tonic-clonic seizures in a childhood absence epilepsy trial
- PMID: 26311751
- PMCID: PMC4603882
- DOI: 10.1212/WNL.0000000000001971
Long-term outcomes of generalized tonic-clonic seizures in a childhood absence epilepsy trial
Abstract
Objective: To determine incidence and early predictors of generalized tonic-clonic seizures (GTCs) in children with childhood absence epilepsy (CAE).
Methods: Occurrence of GTCs was determined in 446 children with CAE who participated in a randomized clinical trial comparing ethosuximide, lamotrigine, and valproate as initial therapy for CAE.
Results: As of June 2014, the cohort had been followed for a median of 7.0 years since enrollment and 12% (53) have experienced at least one GTC. The median time to develop GTCs from initial therapy was 4.7 years. The median age at first GTC was 13.1 years. Fifteen (28%) were not on medications at the time of their first GTC. On univariate analysis, older age at enrollment was associated with a higher risk of GTCs (p=-0.0009), as was the duration of the shortest burst on the baseline EEG (p=0.037). Failure to respond to initial treatment (p<0.001) but not treatment assignment was associated with a higher rate of GTCs. Among patients initially assigned to ethosuximide, 94% (15/16) with GTCs experienced initial therapy failure (p<0.0001). A similar but more modest effect was noted in those initially treated with valproate (p=0.017) and not seen in those initially treated with lamotrigine.
Conclusions: The occurrence of GTCs in a well-characterized cohort of children with CAE appears lower than previously reported. GTCs tend to occur late in the course of the disorder. Children initially treated with ethosuximide who are responders have a particularly low risk of developing subsequent GTCs.
© 2015 American Academy of Neurology.
Figures
References
-
- Berg AT, Shinnar S, Levy SR, et al. How well can epilepsy syndromes be identified at diagnosis? A reassessment 2 years after initial diagnosis. Epilepsia 2000;41:1269–1275. - PubMed
-
- Jallon P, Loiseau P, Loiseau J. Newly diagnosed unprovoked epileptic seizures: presentation at diagnosis in CAROLE study: Coordination Active du Reseau Observatoire Longitudinal de l'Epilepsie. Epilepsia 2001;42:464–475. - PubMed
-
- Hirsch E, Panayatopoulos CP. Childhood absence epilepsy and related syndromes. In: Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, Wolf P, editors. Epileptic Syndromes in Infancy Childhood and Adolescence, 4th ed Montrouge, France: John Libbey Eurotext; 2005:315–335.
-
- Loiseau P, Pestre M, Dartigues JF, Commenges D, Barberger-Gateau C, Cohadon S. Long-term prognosis in two forms of childhood epilepsy: typical absence seizures and epilepsy with rolandic (centrotemporal) EEG foci. Ann Neurol 1983;13:642–648. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01-NS065840/NS/NINDS NIH HHS/United States
- R01-LM011124/LM/NLM NIH HHS/United States
- UL1RR031988/RR/NCRR NIH HHS/United States
- U10-NS077311/NS/NINDS NIH HHS/United States
- NS-78333/NS/NINDS NIH HHS/United States
- R01-NS043209/NS/NINDS NIH HHS/United States
- P50AR060836/AR/NIAMS NIH HHS/United States
- P20 NS080181/NS/NINDS NIH HHS/United States
- U01NS077276/NS/NINDS NIH HHS/United States
- U01 NS045911/NS/NINDS NIH HHS/United States
- R01HD058567/HD/NICHD NIH HHS/United States
- U10NS077308/NS/NINDS NIH HHS/United States
- NS20253/NS/NINDS NIH HHS/United States
- R01-NS053998/NS/NINDS NIH HHS/United States
- NS45911/NS/NINDS NIH HHS/United States
- U01-NS045803/NS/NINDS NIH HHS/United States
- R01-NS062756/NS/NINDS NIH HHS/United States
- 1R01NS053998/NS/NINDS NIH HHS/United States
- P30HD040677/HD/NICHD NIH HHS/United States
- NS43209/NS/NINDS NIH HHS/United States
- 1R01LM011124/LM/NLM NIH HHS/United States
- NS 2R01-NS043209/NS/NINDS NIH HHS/United States
- 2U01-NS045911/NS/NINDS NIH HHS/United States
- R01AR061875/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials